… single inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β 2 -agonist inhaler
… In the TRILOGY study, we aimed to compare the efficacy and safety of single inhaler triple …

… with a single inhaler may offer potential advantages in practicality and therapy adherence
compared with multiple-inhaler therapy [19,20,21]. Recently, single inhalers containing ICS/…

… single-inhaler triple therapy in asthma. Here we report on two studies that compared the
single-inhaler extrafine combination of beclometasone dipropionate (BDP; inhaled corticosteroid…

… single inhaler. Currently, patients with COPD receiving triple therapy must use at least two
inhalers, typically a combined inhaled … these studies used a single inhaler triple combination. …

… ICS; and study design of parallel-group randomised controlled trials of ≥3 months duration.
… and single inhaler triple therapies, which included three of the six single inhaler clinical trials …

… In the new double-blind controlled parallel group study (involving over 2,500 patients)
formoterol/budesonide combination inhaler was used as maintenance therapy twice daily, but …

… albuterol (also known as salbutamol) in a single inhaler would be as effective as the regular
use of inhaled … , randomized, parallel-group trial. After a 4-week run-in, patients with mild …

… This was an open, randomized, parallel group study conducted in 29 Swedish centres.
Adult patients, who had participated in the previous 6 -month study in this subset of centres, …

… -blind, parallel-group study in patients with mild-to-moderate … new asthma management
strategy, a single inhaler containing … overall approach advocated in asthma treatment guidelines, …

… of Symbicort® (budesonide/formoterol in a single inhaler) in children with asthma. This
was a double-blind, double-dummy, randomized, parallel-group, multicenter trial. After a 2–4-…